STOCK TITAN

Emergent BioSolutions to Participate in Virtual Investor Conferences

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags
conferences
Rhea-AI Summary

Emergent BioSolutions (NYSE: EBS) announced participation in two key virtual investor conferences in June 2020. The events include the BMO 2020 Prescriptions for Success Healthcare Virtual Conference on June 23, featuring a fireside chat at 3:00 PM Eastern, and the Three Part Advisors Virtual East Coast IDEAS Investor Conference on June 24, offering a pre-recorded presentation available from 8:00 AM Eastern. The webcasts will cover recent business developments and financial guidance, accessible via the Emergent website.

Positive
  • None.
Negative
  • None.

GAITHERSBURG, Md., June 16, 2020 (GLOBE NEWSWIRE) -- Emergent BioSolutions Inc. (NYSE: EBS) announced today that members of the company’s executive management team will participate in the following virtual investor conferences this month:

  • BMO 2020 Prescriptions for Success Healthcare Virtual Conference
    June 23 – fireside chat at 3:00 pm eastern

  • Three Part Advisors Virtual East Coast IDEAS Investor Conference
    June 24 – pre-recorded presentation available for playback all day beginning at 8:00 am eastern

For these conferences, the company’s webcast presentation may include a discussion of the company's recent business developments as well as its financial results and guidance. The webcasts will be available both live and by replay, accessible from the Emergent website www.emergentbiosolutions.com under “Investors.”

About Emergent BioSolutions
Emergent BioSolutions is a global life sciences company whose mission is to protect and enhance life. Through our specialty products and contract development and manufacturing services, we are dedicated to providing solutions that address public health threats. Through social responsibility, we aim to build healthier and safer communities. We aspire to deliver peace of mind to our patients and customers so they can focus on what’s most important in their lives. In working together, we envision protecting or enhancing 1 billion lives by 2030. For more information visit www.emergentbiosolutions.com. Find us on LinkedIn and follow us on Twitter @emergentbiosolu and Instagram @life_at_emergent.

Investor Contact:
Robert G. Burrows
Vice President, Investor Relations
240-631-3280
burrowsr@ebsi.com 

Media Contact:
Miko B. Neri
Senior Director, Corporate Communications
240-631-3392
nerim@ebsi.com


FAQ

When is Emergent BioSolutions participating in the BMO 2020 Healthcare Virtual Conference?

Emergent BioSolutions will participate in the BMO 2020 Prescriptions for Success Healthcare Virtual Conference on June 23, 2020, with a fireside chat at 3:00 PM Eastern.

What is the date of the Three Part Advisors Virtual East Coast IDEAS Investor Conference?

The Three Part Advisors Virtual East Coast IDEAS Investor Conference is scheduled for June 24, 2020.

Where can I access Emergent BioSolutions' investor conference webcasts?

The webcasts for Emergent BioSolutions' investor conferences will be available live and for replay on their official website under the 'Investors' section.

What topics will Emergent BioSolutions discuss during the investor conferences?

Emergent BioSolutions will discuss recent business developments and their financial results and guidance during the investor conferences.

What is the stock symbol for Emergent BioSolutions?

The stock symbol for Emergent BioSolutions is EBS.

Emergent Biosolutions, Inc.

NYSE:EBS

EBS Rankings

EBS Latest News

EBS Stock Data

455.69M
53.00M
2.09%
57.86%
12.82%
Drug Manufacturers - Specialty & Generic
Pharmaceutical Preparations
Link
United States of America
GAITHERSBURG